Practice Patterns About Management of Allergic Rhinitis: Indian HCP KAP Experience in 2024 and Preference of Fexofenadine and Montelukast Dr. Kamal Kant Kohli29 Oct 2024 10:00 AM ISTAllergic Rhinitis (AR) is the most common immune-mediated inflammatory condition affecting the nasal mucosa (1) triggered by the production of IgE...
Allergic Rhinitis and ENT Practice: Review and Evidence Emphasis on Fluticasone Furoate Dr. Kamal Kant Kohli11 July 2024 12:00 PM ISTAllergic rhinitis (AR) affects approximately 25% and 40% of children and adults globally, respectively. In 80% of the cases, the symptoms occur before...
Allergic Rhinitis and Co-morbid Asthma: All Clinician Needs to Know and Consideration of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli6 May 2024 11:30 AM ISTAllergic rhinitis (AR), a prevalent non-infectious disease condition; is an IgE-mediated response to allergens, causing symptoms like sneezing,...
Indian Guidelines Review on Allergic Rhinitis and Scope for Use of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli22 Jan 2024 11:00 AM ISTAllergic Rhinitis and Its Burden in India: Allergic rhinitis (AR) is a common inflammatory condition that affects the nasal mucosa and is...
Allergens in India and its Avoidance: Review through Indian Guidelines and Role of Fexofenadine-Montelukast Combination Dr. Kamal Kant Kohli4 Dec 2023 12:13 PM ISTAllergic rhinitis is one of the most common allergic diseases, which appears to increase in India. Risk factors, diagnosis, and AR management vary...
Allergic Rhinitis: Latest Practice Insights and Treatment Approach Dr. Kamal Kant Kohli3 Nov 2023 11:13 AM ISTUnderstanding Allergic Rhinitis(AR)Rhinitis is generally defined as inflammation of the nasal mucosa. Allergic rhinitis (AR) is a disease that affects...
